NCT06247189 ICOPE Program Feasibility in the Management of Myeloma Patients
| NCT ID | NCT06247189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-12-03 |
| Primary Completion | 2026-12-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-12-03 with a primary completion date of 2026-12-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
Eligibility Criteria
Inclusion Criteria: * Male or female aged over 70 years, * Patient with multiple myeloma * WHO performance status 0-3, * Patient eligible for first- or second-line treatment * Patient willing to participate in ICOPE MONITOR program * Patient or caregiver able to use digital tools of ICOPE MONITOR: application or chatbot (computer or tablet or smartphone) * Patient with a life expectancy of more than 3 months, * Patient or caregiver able to understand, read and speak French * Person affiliated or benefiting from a social security. * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research) Exclusion Criteria: * Patient in palliative care * Patient participating in a study evaluating another frailty prevention program * Patient unable to understand the study * Patient under court protection, guardianship or curatorship, * Patient refusal.
Contact & Investigator
Gilles BOURGADE
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT06247189 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06247189 currently recruiting?
Yes, NCT06247189 is actively recruiting participants. Contact the research team at bourgade.g@chu-toulouse.fr for enrollment information.
Where is the NCT06247189 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT06247189 clinical trial?
NCT06247189 is sponsored by University Hospital, Toulouse. The principal investigator is Gilles BOURGADE at University Hospital, Toulouse. The trial plans to enroll 30 participants.